– Significant unmet need for safe and effective oral therapies in UC for patients with inadequate response, loss of response or intolerance to conventional or advanced therapies SAN DIEGO--(BUSINESS ...
- Significant unmet need for new effective therapies exists in ulcerative colitis - ELEVATE UC clinical trial sites continue to initiate SAN DIEGO, June 17, 2019 /PRNewswire/ -- Arena Pharmaceuticals, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results